RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Md Nurunnabi to Drug Delivery Systems

This is a "connection" page, showing publications Md Nurunnabi has written about Drug Delivery Systems.
Connection Strength

3.145
  1. Badruddoza AZM, Zahid MI, Walsh T, Shah J, Gates D, Yeoh T, Nurunnabi M. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance. Int J Pharm. 2024 Jun 10; 658:124210.
    View in: PubMed
    Score: 0.827
  2. Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022 11; 351:504-559.
    View in: PubMed
    Score: 0.740
  3. Kumar R, Afrin H, Bhatt HN, Beaven E, Gangavarap A, Esquivel SV, Zahid MI, Nurunnabi M. Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment. ACS Appl Mater Interfaces. 2024 Jan 10; 16(1):305-317.
    View in: PubMed
    Score: 0.202
  4. Beaven E, Kumar R, An JM, Mendoza H, Sutradhar SC, Choi W, Narayan M, Lee YK, Nurunnabi M. Potentials of ionic liquids to overcome physical and biological barriers. Adv Drug Deliv Rev. 2024 01; 204:115157.
    View in: PubMed
    Score: 0.201
  5. Esquivel SV, Bhatt HN, Diwan R, Habib A, Lee WY, Khatun Z, Nurunnabi M. ?-Glucan and Fatty Acid Based Mucoadhesive Carrier for Gastrointestinal Tract Specific Local and Sustained Drug Delivery. Biomolecules. 2023 04 28; 13(5).
    View in: PubMed
    Score: 0.193
  6. Afrin H, Geetha Bai R, Kumar R, Ahmad SS, Agarwal SK, Nurunnabi M. Oral delivery of RNAi for cancer therapy. Cancer Metastasis Rev. 2023 09; 42(3):699-724.
    View in: PubMed
    Score: 0.191
  7. Chowdhury MMH, Salazar CJJ, Nurunnabi M. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomater Sci. 2021 Jul 13; 9(14):4821-4842.
    View in: PubMed
    Score: 0.170
  8. Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T, Nurunnabi M. Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications. ACS Biomater Sci Eng. 2021 06 14; 7(6):2106-2149.
    View in: PubMed
    Score: 0.168
  9. Sun T, Dasgupta A, Zhao Z, Nurunnabi M, Mitragotri S. Physical triggering strategies for drug delivery. Adv Drug Deliv Rev. 2020; 158:36-62.
    View in: PubMed
    Score: 0.158
  10. Muthiah M, Park SH, Nurunnabi M, Lee J, Lee YK, Park H, Lee BI, Min JJ, Park IK. Intracellular delivery and activation of the genetically encoded photosensitizer Killer Red by quantum dots encapsulated in polymeric micelles. Colloids Surf B Biointerfaces. 2014 Apr 01; 116:284-94.
    View in: PubMed
    Score: 0.101
  11. Khatun Z, Nurunnabi M, Reeck GR, Cho KJ, Lee YK. Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy. J Control Release. 2013 Aug 28; 170(1):74-82.
    View in: PubMed
    Score: 0.097
  12. Mondal J, Chakraborty K, Bunggulawa EJ, An JM, Revuri V, Nurunnabi M, Lee YK. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment. J Control Release. 2024 Aug; 372:1-30.
    View in: PubMed
    Score: 0.052
  13. Shahriar SMS, Nafiujjaman M, An JM, Revuri V, Nurunnabi M, Han DW, Lee YK. Graphene: A Promising Theranostic Agent. Adv Exp Med Biol. 2022; 1351:149-176.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support